<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01943812</url>
  </required_header>
  <id_info>
    <org_study_id>Skive-2013-BA</org_study_id>
    <nct_id>NCT01943812</nct_id>
  </id_info>
  <brief_title>Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation</brief_title>
  <official_title>Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peter Humaidan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regionshospitalet Viborg, Skive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare two FET protocols by modifying the substituted FET cycle
      in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early
      pregnancy loss.

      Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early
      pregnancy loss.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy loss rate</measure>
    <time_frame>Primary outcome is avaible after 12th week of gestational.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>14 days after embryo transfer.</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Luteal progesterone levels</measure>
    <time_frame>7th week of gestation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">722</enrollment>
  <condition>Pregnancy Loss</condition>
  <condition>Frozen Embryo Transfer</condition>
  <arm_group>
    <arm_group_label>Substituted FET cycle and GnRHa</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Substituted FET GnRH-a 2 bolus two days before Estradiol 6 mg Progesterone (Crinone) 180 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Substituted FET cycle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>substituted FET cycle Estradiol Progesterone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Estradiol and progeterone</intervention_name>
    <description>Estradiol and progesterone</description>
    <arm_group_label>Substituted FET cycle and GnRHa</arm_group_label>
    <arm_group_label>Substituted FET cycle</arm_group_label>
    <other_name>Estradiol and progesterone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Endometrial thickness â‰¥ 7 mm after stimulation

          -  18-45 years

          -  IVF/ICSI fertilisation

          -  BMI &gt; 18,5 &lt;30 kg/m2

          -  cycle length 25-34 days

        Exclusion Criteria:

          -  endometrial thickness &lt; 7 mm or no triple layer endometrium and/or functional
             follicles

          -  Uterine abnormality

          -  Chronic medical disease

          -  oocyte donation cycles
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Birgit Alsbjerg, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic Regional Hospital Skive</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Birgit Alsbjerg, M.D.</last_name>
    <phone>+45 78 44 57 60</phone>
    <email>birgit.alsbjerg@viborg.rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Peter Humaidan, D.M.Sc.</last_name>
    <phone>+45 78 44 57 60</phone>
    <email>peter.humaidan@viborg.rm.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>IVF syd</name>
      <address>
        <city>Fredericia</city>
        <zip>7000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steen B Laursen, Ph.D.</last_name>
      <phone>+45 76 24 50 20</phone>
    </contact>
    <investigator>
      <last_name>Steen B Lauersen, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fertility Clinic Regional Hospital Skive</name>
      <address>
        <city>Skive</city>
        <zip>7800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgit Alsbjerg, M.D.</last_name>
      <phone>+45 78 44 57 60</phone>
    </contact>
    <investigator>
      <last_name>Birgit Alsbjerg, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2013</study_first_submitted>
  <study_first_submitted_qc>September 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2013</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regionshospitalet Viborg, Skive</investigator_affiliation>
    <investigator_full_name>Peter Humaidan</investigator_full_name>
    <investigator_title>D.M.Sc., M.D.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Estradiol</mesh_term>
    <mesh_term>Polyestradiol phosphate</mesh_term>
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Estradiol 3-benzoate</mesh_term>
    <mesh_term>Estradiol 17 beta-cypionate</mesh_term>
    <mesh_term>Estradiol valerate</mesh_term>
    <mesh_term>Deslorelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

